> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Techsomed Ablation Planning Software Cleared
- URL: https://www.fdaweb.com/techsomed-ablation-planning-software-cleared/
- Published: 2023-09-05T12:00:00.000Z
- Updated: 2026-09-14T18:54:21.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5155250

FDA has cleared a Techsomed 510(k) for its VisAble.IO software intended to assist physicians in planning liver ablation procedures and confirming ablation zones. The device uses the company’s BioTrace solution, an “end-to-end software solution for full visualization and control for image guided ablation therapy,” Techsomed says. “By utilizing AI-based technology, BioTrace leverages standard imaging—such as ultrasound (US) along with computed tomography (CT) or magnetic resonance imaging (MRI) to provide visualization of the full extent of the ablation zone in real-time, together with smart, personalized treatment planning and assessment tools, allowing physicians to provide their patients with optimized care,” it says.

The software’s key features include 3D visualization of the ablation target within a patient-specific anatomical view, overlay and position of virtual instruments and estimated ablation regions onto medical images, and an interactive 3D view of ablation margins and missed volumes to help users evaluate ablation target coverage after a procedure, according to Techsomed.